Clinical Trial Update: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long) [Phase 2, Phase 3]

View source ↗

Summary

The document reports the completion of Phase 2 and Phase 3 trials evaluating the new bioactive compound Metobes-Long for weight loss maintenance in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Metobes-Long

Snippet

Sponsor: University of Copenhagen | Conditions: Obesity | Phase 2, Phase 3 | Status: COMPLETED